This rate is nearly double the U.S. national average of 37.5 prescriptions per 100 persons, highlighting a significant factor in the state's opioid crisis.
Key Takeaways on Opioid Use Disorder in Arkansas
- Arkansas has the fourth-highest rate of Opioid Use Disorder (OUD) diagnoses in the United States.4th Highest[2]
- A significant treatment gap exists, with only 55% of Arkansans diagnosed with OUD receiving any form of treatment.45% Untreated[3]
- The state saw a nearly 40% jump in OUD diagnoses following the onset of the COVID-19 pandemic.~40% Increase[2]
- Young adults aged 18-25 are disproportionately affected, with an OUD prevalence rate of 4.1%, higher than the state's overall adult rate.4.1%[3]
- In 2023, Arkansas recorded approximately 1,200 deaths from opioid overdoses.1,200 Deaths[4]
- Access to care is a major challenge, with only one mental health provider for every 8,500 residents in the state.1 to 8,500[5]
- Over 65% of individuals with OUD in Arkansas are covered by Medicaid, indicating a heavy reliance on public health services for treatment.>65% on Medicaid[6]
The Opioid Crisis in Arkansas: An Overview
Arkansas is facing a significant public health crisis related to Opioid Use Disorder (OUD), with one of the highest diagnosis rates in the nation[2]. The situation is compounded by a historically high rate of opioid prescriptions and underlying social determinants of health, such as poverty and limited community resources, which can contribute to the onset and persistence of OUD[7]. Understanding the scope of this issue through data is the first step toward developing effective interventions and support systems for affected individuals and communities.
Opioid Use Disorder (OUD)
Source: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Text Revision. American Psychiatric Association; 2022.
Prevalence of OUD in Arkansas
The prevalence of Opioid Use Disorder in Arkansas is a key indicator of the crisis's scale. In 2021, the 12-month prevalence rate of OUD among adults in the state was approximately 3.2%[3], a figure notably higher than the national average of 2.5%[7]. While national data suggests most prescription pain reliever disorders are predominantly mild[8], the high rate of prescribing in Arkansas, including 60 prescriptions per 100 high-risk individuals aged 65 and older[9], elevates the overall risk for the population.
Arkansas vs. National OUD Prevalence
Demographics and At-Risk Populations
Opioid Use Disorder does not affect all populations equally. In Arkansas, specific demographic groups face a higher risk. Data reveals disparities based on age and geography, with young adults and those in rural communities being particularly vulnerable. For instance, treatment access is often amplified as a problem in rural areas where healthcare resources are scarcer than in urban centers[2]. Additionally, racial and ethnic minorities in these rural communities are often disproportionately affected by the crisis[3].
Post-Pandemic Trends
The COVID-19 pandemic exacerbated the opioid crisis in Arkansas, leading to significant increases in OUD cases across various regions and demographics. The stress, social isolation, and disruption to healthcare services during the pandemic are considered contributing factors to this surge. This trend highlights the vulnerability of at-risk populations during public health emergencies and the need for resilient and accessible addiction treatment infrastructure.
OUD Case Increases Since the Pandemic
Post-pandemic surge compared to previous levels.
Increase in 2025 compared to the previous year.
Increase in the post-pandemic period.
Barriers to Treatment and Access to Care
Despite the high prevalence of OUD, many Arkansans face significant hurdles in accessing treatment. Systemic obstacles such as a shortage of providers, lack of funding, and insurance barriers prevent many from receiving timely and adequate care[2]. These factors contribute to worsening outcomes and highlight a critical need for investment in the state's healthcare infrastructure[11]. Many counties in the state are officially designated as Health Professional Shortage Areas (HPSAs) for mental health, further illustrating the challenge[15].
Treatment Gaps by the Numbers
Statewide Disparities in Care
When comparing Arkansas to national benchmarks, critical gaps in the state's healthcare system become apparent. The density of treatment providers and the extent of insurance coverage for mental health services are both lower than the national average. These systemic shortfalls create significant disparities, particularly for residents in rural counties who face even greater challenges in finding and paying for care.
Access to Care: Arkansas vs. National Average
Health Outcomes: Overdoses and Suicide
The consequences of widespread OUD and insufficient treatment access are severe, manifesting in tragic outcomes like overdose deaths and elevated suicide rates. The high rate of co-occurring mental health conditions among individuals with OUD means that substance use and suicide risk are often tragically linked[18]. This underscores the urgent need for integrated care that addresses both substance use and mental health concurrently.
Suicide Rate per 100,000 Residents (2023)
Policy Initiatives and Positive Trends
In response to the crisis, Arkansas has implemented several initiatives aimed at improving outcomes. The state has been recognized as a national leader in efforts to reduce opioid prescriptions through programs like the Prescription Drug Monitoring Program (PDMP)[19]. Recent legislation has also expanded mental health parity and increased Medicaid reimbursement for OUD treatment services[20]. Furthermore, the use of telehealth for substance use treatment has expanded, offering a new avenue for care, though its adoption remains below optimal levels[8].
Signs of Progress in Arkansas
Achieved in 2023 compared to the previous year, according to the state's PDMP.
Decline from 45% in 2020 to 36% in 2023 due to a targeted initiative.
Growth in providers of Medication-Assisted Treatment compared to 2022.
Frequently Asked Questions
Sources & References
All statistics and claims on this page are supported by peer-reviewed research and official government data sources.
